Table 1 Characteristics of participants in the Ketamine trial.
Diagnosis group | Sex | N (Total 20) | Chronological age (mean ± SD) | PCL-5 baseline (mean ± SD) | PHQ-9 baseline (mean ± SD) |
|---|---|---|---|---|---|
PTSD only | Female | 4 | 37.16 ± 10.64 | 42.25 ± 7.89 | 8.25 ± 4.43 |
Male | 1 | 33.36 | 48.00 | 11.00 | |
MDD only | Female | 2 | 43.81 ± 4.75 | 23.00 ± 8.49 | 18.00 |
Comorbid MDD & PTSD | Female | 9 | 43.38 ± 11.28 | 57.11 ± 8.24 | 19.22 ± 3.96 |
Male | 4 | 36.19 ± 20.15 | 53.50 ± 12.87 | 21.00 ± 2.83 |
